Impact of very early antiretroviral therapy during acute HIV infection on long-term immunovirological outcomes

Impact of very early antiretroviral therapy during acute HIV infection on long-term immunovirological outcomes

Objectives: We aimed to determine if starting antiretroviral therapy (ART) in the first 30 days after acquiring HIV infection has an impact on immunovirological response. Methods: Observational, ambispective study including 147 patients with confirmed acute HIV infection (January/1995-August/2022)....

Full description

Bibliographic Details
Main Authors:	Paula Suanzes, Jordi Navarro, Ariadna Rando-Segura, Patricia Álvarez-López, Jorge García, Vicente Descalzo, Arnau Monforte, Maider Arando, Lucía Rodríguez, Bibiana Planas, Joaquín Burgos, Adrian Curran, María José Buzón, Vicenç Falcó
Format:	Article
Language:	English
Published:	Elsevier 2023-11-01
Series:	International Journal of Infectious Diseases
Subjects:	HIV infection Acute HIV infection Immune recovery CD4+/CD8+ ratio Antiretroviral treatment Early treatment
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971223007221

Similar Items

Viral suppression and adherence among HIV‐infected children and adolescents on antiretroviral therapy: results of a multicenter study
by: Maria L.S. Cruz, et al.
Published: (2014-11-01)

Predictors of a high incidence of opportunistic infections among HIV-infected children receiving antiretroviral therapy at Amhara regional state comprehensive specialized hospitals, Ethiopia: A multicenter institution-based retrospective follow-up study
by: Gebrehiwot Berie Mekonnen, et al.
Published: (2023-05-01)

Durability of first-line antiretroviral treatment in the Russian Federation: retrospective study
by: N. V. Sizova, et al.
Published: (2023-10-01)

Prevalence of severe cardiovascular abnormalities amongst West African HIV-infected patients on antiretroviral therapy followed at a referral HIV centre
by: Frederic N. Ello, et al.
Published: (2021-02-01)

Influence of immunodeficiency and systemic use of antiretroviral drugs on the structure of skin and mucosa diseases in patients with HIV infection
by: A. S. Podymova, et al.
Published: (2016-09-01)

One size doesn’t fit all: Tailoring adult antiretroviral treatment
by: Nathan Geffen, et al.
Published: (2014-09-01)

CLINICAL AND IMMUNOLOGICAL CHARACTERISTICS OF HIV-INFECTION IN DYNAMICS AGAINST THE BACKGROUND OF ANTIRETROVIRAL THERAPY AMONG PATIENTS IN POLTAVA REGION
by: O.H. Marchenko, et al.
Published: (2019-12-01)

The outcome of intervention, characteristics, and determinants of treatment failure in HIV-infected adolescents on first-line antiretroviral therapy at a tertiary health institution, in South-east Nigeria
by: Maria-Lauretta Orji, et al.
Published: (2021-01-01)

Antiretroviral therapy of acute HIV-infection
by: A V Kravchenko, et al.
Published: (2004-04-01)

Evaluation of Prognostic response in HIV positive patients after Antiretroviral Therapy
by: Nadya Usman, et al.
Published: (2020-09-01)

Evaluation of multi-assay algorithms for cross-sectional HIV incidence estimation in settings with universal antiretroviral treatment
by: Wendy Grant-McAuley, et al.
Published: (2022-11-01)

Treatment outcome of different antiretroviral drug regimens in HIV-positive pregnant women
by: Nidhi Chauhan, et al.
Published: (2021-01-01)

Adherence, safety and efficacy of antiretroviral therapy among children at a tertiary hospital in India
by: Kiran Rajput, et al.
Published: (2022-04-01)

Prevalence of depression among HIV-positive patients treated with antiretrovirals at different stage of infection
by: Yasir Alvi, et al.
Published: (2018-11-01)

Plasma metabolomic profile is near-normal in people with HIV on long-term suppressive antiretroviral therapy
by: Ana Virseda-Berdices, et al.
Published: (2024-03-01)

Diagnosis, antiretroviral therapy, and emergence of resistance to antiretroviral agents in HIV-2 infection: a review
by: Maia Hightower, et al.

Access to antiretroviral treatment in South Africa, 2004 - 2011
by: Leigh Francis Johnson
Published: (2012-03-01)

Efficacy of antituberculosis therapy in combination with antiretroviral therapy in patients with co-infection TB/HIV
by: Kryzhanovsky D.G., et al.
Published: (2013-03-01)

Current antiretroviral therapy: A review
by: Alexey V. Kravchenko, et al.
Published: (2023-12-01)

Assessment of the comorbidity index in HIV-infected patients before ART
by: D. M. Urunova, et al.
Published: (2022-10-01)

A randomized prospective study to compare early versus delayed access to antiretroviral therapy over clinical and immunological sequel in HIV-positive adults
by: Vikas Kumar, et al.
Published: (2022-01-01)

Rapid initiation of antiretroviral therapy in Turkey: a modeling study
by: Emine Yaylali, et al.
Published: (2024-01-01)

Pengaruh Terapi Vitamin D Terhadap Kadar Kalsidiol dan CD4 pada Anak dengan Human Immunodeficiency Virus Dalam Terapi Antiretroviral
by: Reza Chandra Abdilla, et al.
Published: (2021-10-01)

Antiretroviral therapy interruptions: impact on HIV treatment and transmission
by: Dubrocq G, et al.
Published: (2018-06-01)

Trends of CD4 cell count levels at the initiation of antiretroviral therapy over time and factors associated with late initiation of antiretroviral therapy among Asian HIV‐positive patients
by: Sasisopin Kiertiburanakul, et al.
Published: (2014-01-01)

Profile of once-daily darunavir/cobicistat fixed-dose combination for the treatment of HIV/AIDS
by: Navarro J, et al.
Published: (2016-10-01)

Treatment during primary HIV infection does not lower viral set point but improves CD4 lymphocytes in an observational cohort
by: Koegl C, et al.
Published: (2009-07-01)

Cardiovascular pathology in HIV-infection during antiretroviral therapy
by: Renata G. Tuaeva, et al.
Published: (2024-02-01)

THE INFLUENCE OF HIV INFECTION DURATION BEFORE ANTIRETROVIRAL THERAPY ON IMMUNOLOGICAL TREATMENT FAILURE
by: A. F. Oleynik, et al.
Published: (2017-06-01)

The long-term outcomes of antiretroviral treatment initiated with mono or dual nucleoside reverse transcriptase inhibitors in HIV-1-infected children: an Asian observational study
by: Orasri Wittawatmongkol, et al.
Published: (2015-07-01)

Antiretroviral treatment, government policy and economy of HIV/AIDS in Brazil: is it time for HIV cure in the country?
by: Adele S. Benzaken, et al.
Published: (2019-08-01)

Pregnancy rates and outcomes in a longitudinal HIV cohort in the context of evolving antiretroviral treatment provision in South Africa
by: Nivashnee Naicker, et al.
Published: (2022-07-01)

Raltegravir is the first HIV integrase inhibitor as part of antiretroviral treatment regimens
by: Aleksey Viktorovich Kravchenko, et al.
Published: (2010-11-01)

A New Combined Antiretroviral Therapy In Adolescents With HIV: Bictegravir/Emtricitabine/Tenofovir Alafenamide
by: Neslihan Mete Atasever, et al.
Published: (2024-12-01)

How children access antiretroviral treatment at Kgapane District Hospital, Limpopo, South Africa
by: J. Railton, et al.
Published: (2012-06-01)

Factors Associated With Delayed and Late Initiation of Antiretroviral Therapy Among Patients With HIV in Beijing, China, 2010–2020
by: Yuanqi Mi, et al.
Published: (2023-06-01)

Response to antiretroviral therapy undergone by HIV/AIDS patients
by: Nanang Munif Yasin, et al.
Published: (2011-07-01)

Immunovirological discordance among female sex workers who start antiretroviral therapy in Burkina Faso
by: Wilfried Wenceslas Bazié, et al.
Published: (2022-02-01)

Increased CD4+ T cell count is associated with lower anal human papillomavirus prevalence among HIV-positive male cohort in Taizhou, China: a cross-sectional study
by: Jing Zhang, et al.
Published: (2022-03-01)

HIV persistence in the setting of antiretroviral therapy: when, where and how does HIV hide?
by: Deanna A. Kulpa, et al.
Published: (2015-04-01)